With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...
Angelini Pharma has agreed to acquire all outstanding shares of Catalyst Pharmaceuticals (CPRX) for $31.50 per share in cash, for a total equity value of approximately $4.1B. The deal has been ...
New dimensional theory: Physicists propose that three extra curled-up dimensions could create a torsion field preventing black holes from fully evaporating. Solving old paradox: The model offers a ...
State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...
SANTA CRUZ — A small group of music fans and Santa Cruz City Council candidates have created a petition in hopes of saving the Catalyst Club in downtown Santa Cruz. The building at 1011 Pacific Ave.
Seven dimensions theory: Researchers suggest extra dimensions could create torsion fields that stop black hole evaporation, preserving information indefinitely. Backward time messaging: Physicists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results